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Accurateassessmentsofintravascularﬂuidstatusareanessentialpartofperioperativecareandnecessaryinthemanagementofthe
hemodynamically unstablepatient.Goal-directed ﬂuidmanagementcan facilitateresuscitation ofthehypovolemic patient,reduce
the risk of ﬂuid overload, reduce the risk of the injudicious use of vasopressors and inotropes, and improve clinical outcomes.
In this paper, we discuss the strengths and limitations of a spectrum of noninvasive and invasive techniques for assessing and
monitoring intravascular volume status and ﬂuid responsiveness in the perioperative and critically ill patient.
1.Introduction
The ability to assess intravascular volume is an essential part
of perioperative care and the management of perioperative
hemodynamic instability. Insuﬃcient intravascular volume
can result in decreased oxygen delivery to tissues and organ
dysfunction, while ﬂuid overload states can contribute to
the development of edema and organ dysfunction, including
respiratory failure. The injudicious use of vasopressors and
inotropes in the hypovolemic patient can be hazardous and
increase the risk of a poor outcome.
Two concepts are relevant to assessments of ﬂuid status
in perioperative and critical care. Euvolemia describes a state
of normal body ﬂuid volume that allows adequate ﬁlling of
the cardiac chambers and, in turn, makes it possible for the
hearttoproduceacardiacoutputthatcanmeettheorganism
oxygen demand. In the setting of euvolemia, neither diuresis
nor ﬂuid administration is necessary. Fluid responsiveness
describes the ability of the heart to respond to ﬁlling volume
variations, modifying its stroke volume and consequently
the cardiac output. From a patient management perspective,
ﬂuid responsiveness determines the extent to which circula-
tory homeostasis can be maintained with ﬂuids alone versus
the need for inotropes or vasopressors. An understanding of
both concepts derives from the Frank-Starling relationship
describing the changes in cardiac stroke volume in response
to changes in cardiac preload. The ascending portion of the
Frank-Starling curve will correspond to the ﬂuid responsive
phase of resuscitation, as seen with an increase in the cardiac
output. Once the left ventricle reaches the plateau phase of
the curve, ﬂuid administration will not improve the cardiac
output any further; it may lead to the adverse eﬀects related
to ﬂuid overloading, such as hydrostatic pulmonary edema.
In a broad sense, if euvolemia is the goal of ﬂuid use in
resuscitation, then ﬂuid responsiveness reﬂects the process
of working toward establishing euvolemia. In evaluating the
various techniques for analyzing ﬂuid status, it is helpful to
contrast their utility in predicting ﬂuid responsiveness versus
euvolemia and to consider how these relative strengths and
weaknesses may be paired with diﬀerent clinical situations
to yield accurate and meaningful information. Methods
of interpreting intravascular volume range from clinical
assessments such as inspection of veins and passive leg
raising, to more invasive methods such as central venous
and pulmonary artery catheterization, to newer technically2 Anesthesiology Research and Practice
intensive methods such as echocardiography and analysis of
ﬂow parameters.
2. Assessment of Fluid Statusby
PhysicalExamination
Only extremes of body water can be predicted by clinical
examination. Tachycardia and hypotension and loss of skin
turgor are associated with frank hypovolemia in unanaes-
thetized adults, while tenting of skin and sunken eyes and
fontanelscanbefoundininfants.Theabilitytodetecthyper-
volemia is more dependent upon cardiac pathology where
smaller grades of ﬂuid excess can produce ﬁndings such
as rales, a third heart sound, oxygen desaturation, jugular
vein distension, and peripheral edema. In operative patients,
experienced clinicians can often predict hypovolemia from
the clinical situation. Fluid deﬁcits resulting from a patient’s
nil per os (NPO) status and use of inhalational agents and
positivepressureventilationearlyinacaseareusuallyindica-
tive of relative hypovolemia, and anesthesiologists typically
respond by increasing the volume of infused ﬂuids. Blood
loss and release of inﬂammatory mediators can also reduce
blood volume, preload, and vascular tone in latter phases of
anoperation,when,again,additional boluseswouldlikelybe
given with careful assessment of the blood pressure response.
Depending on patient position and access, examination
of neck veins and passive leg raising test can yield useful
information. The passive leg raising test (PLR) delivers a
reversible endogenous ﬂuid challenge by increasing venous
return resulting from elevating the legs to 45 degrees in a
supine patient and evaluating its eﬀect on blood pressure
and heart rate. One simple described way to perform PLR
is by using the pivotal motion of the bed to transfer a 45
degree recumbent patient into a horizontal position with
supine trunk and elevated legs [1]. This technique recruits
the splanchnic blood in addition to the blood from lower
extremities, in contrast to simply elevating legs in a supine
patient. PLR test has shown good correspondence with other
derived indices to predict ﬂuid responsiveness in patients
withsepsisandpancreatitis[2]andhasbeenspeciﬁcallyeval-
uated with transthoracic echo [3] and esophageal Doppler
[4] in mechanically ventilated patients. Most operative
situations will preclude the use of PLR and likely prompt
the clinician to assess the response to a ﬂuid bolus. However,
in evaluating patients postoperatively, this simple technique
may be useful.
3.InvasivePressureMonitoring
3.1.CentralVenousPressure(CVP). CVPisthemeasurement
of pressures within the thorax in the superior vena cava
(SVC) and serves as a reasonable surrogate for the corre-
sponding right atrial pressures. CVP is the most widely used
technique for measuring intravascular volume in critically ill
patients [5].
The CVP pressure tracing consists of three positive
waves (a, c, and v) and two negative waves (x and y). The
CVP is speciﬁcally measured at the “z” point of the CVP
ac v
Figure 1: A typical CVP waveform (lower tracing) and accompa-
nying electrocardiogram (upper). The a, c, and v waves are shown,
along with the z point (arrow), indicating the appropriate time in
the cardiac cycle for CVP measurement. All analyses need to occur
at end expiration.
tracing which corresponds to the leading edge of the c
wave (Figure 1). At this part of the cardiac cycle, the
catheter tip is in continuity with the ventricle and hence
aﬀords the best estimate of cardiac preload [6]. As with
the measurement of jugular venous distension, the reference
point for measurement of the CVP is the midaxillary line in
the ﬁfth intercostals space. Numerical recordings of CVP are
measured at end expiration, a time in the respiratory cycle
where the opposing forces of lung elasticity and chest recoil
are balanced and exert the least pressure on the central and
pulmonary vasculature. In patients with forcible expiration,
the true CVP may be better represented by a value at the start
of expiration [6]. Failure to attend to these basic principles
will lead to erroneous data with little reproducibility across
multiple users and time points.
In our experience, single point estimates of CVP are of
limited clinical value unless they are low (<5mmHg) and
conﬁrm an existing suspicion for hypovolemia. Trends and
their correspondence to clinical evidence of organ function
and perfusion help to create a more meaningful picture of
ﬂuid needs and euvolemia. The standard for testing volume
responsiveness is to give a ﬂuid challenge. This involves
giving ﬂuids to increase the CVP by 2mmHg and then
determining whether it increased the CO [7]. In a study
of 83 ICU patients, Magder and Bafaqeeh showed that
patients who were able to increase the CVP by 2mmHg
after receiving a bolus of approximately 500mL of isotonic
crystalloids over 10–30 minutes had a cardiac index increase
of 300mL/min/m2. The two important ﬁndings of the study
were that only 4.5% of the patients with a CVP more
than 10mmHg responded to a ﬂuid challenge, also of the
patients who had increase in CO, 42% had a simultaneous
increase in blood pressure. Therefore, the two conclusions
from the study were that patients with a CVP of more than
10mmHg were poor responders to volume infusion and
that10mmHgmayrepresenteuvolemiainmostindividuals.
Second, blood pressure increase was not a good indicator of
cardiac response to a ﬂuid challenge [8].Anesthesiology Research and Practice 3
The Society of Critical Care Medicine’s Surviving Sepsis
protocol recommends to ﬂuid resuscitate a septic patient to
a target CVP goal of 8–12mmHg and 12–15mmHg in a
mechanically ventilated patient [9]. Though these recom-
mendations are part of a sepsis care bundle that has been
shown to improve survival, the CVP should not be inter-
pretedinisolation,butratherinconjunctionwiththecardiac
output.DependingonwherethepatientisontheFrankStar-
ling curve, some patients may be adequately resuscitated at a
CVP of 6-7mmHg, while others may still be hypovolemic at
10mmHg.
The discussion above applies to use of jugular and sub-
clavian veins. If these sites are not available, femoral vein line
pressures have been shown to be a good substitute for CVP.
In various studies in spontaneously breathing and ventilated
patients, inferior vena cava pressures have been shown to be
around 0.5mmHg lower than the SVC pressures on average
and rarely more than 3mmHg diﬀerent [10]. Though the
readings have been shown to be reliable in patients receiving
mechanical ventilation and high positive end expiratory
pressure, the same rule cannot be applied to patients with
raised intra-abdominal pressures, as encountered during
laparoscopy.
AhealthypersoncanhaveaCVPlessthanzeroinupright
position and still have an adequate CO and be euvolemic.
Conversely, CVP can be high in a patient with poor ventricu-
lar function and low cardiac output or with a good ventricu-
lar function and volume overload [6]. As illustrated by these
commonscenarios,valuesderivedfrompressurereadingsare
most useful when used in conjunction with a dynamic clini-
cal response such as blood pressure or urine output, or some
measure of cardiac output. Echocardiography, analysis of
venous oxyhemoglobin saturation, and immediate changes
in blood pressure have all been used in this regard.
Another distinct advantage of central venous catheteri-
zation is the ability to obtain simultaneous measurements of
pressure or pressure change and central venous saturations
(ScvO2) with a single device. ScvO2 values of more than 70%
areconsistentwithanadequatecardiacoutputandperfusion
status, although this relationship is true only with adequate
hemoglobin levels and stable oxygen requirements (VO2)o f
the body. The early goal-directed therapy for severe sepsis
and septic shock has ScvO2 monitoring as an integral part of
theresuscitationgoals[11].Intermittentbloodsamplingand
catheterswithspecialsensorsareequallyeﬃcaciousmeansof
measuring ScvO2.
3.2. Pulmonary Artery Catheters (PACs) and Pulmonary
Artery Occlusion (Wedge) Pressures. Aberrations in right
heart compliance and pulmonary vascular resistance as may
arisefromcardiacandlungpathologycandrasticallyalterthe
relationship between CVP and left heart preload. Pulmonary
artery catheterization has therefore remained an attractive
option to measure both right and left heart and pulmonary
artery pressures in critically ill patients with such underlying
pathology.Themonitorisbasedonaballoon-tippedcatheter
that “ﬂoats” through the right atrium and ventricle and into
the pulmonary artery as it is advanced. When “wedged” in
one of the proximal branches of the pulmonary artery (PA),
thecatheterisincontinuitywiththeleftventricle.Withsome
minorgradientsinbetweenstructures,aslongasthecatheter
istheWestZoneIIIofthelungandnomitralvalvepathology
is present, the following relationship exists.
3.3. Wedge Pressure ∝ Left Atrial Pressure ∝ Left Ventricular
End-Diastolic Pressure (LVEDP). When pulmonary vascular
resistance is not elevated, the PA diastolic pressure approx-
imates the pulmonary artery wedge pressure (PAWP) and
provides a useful estimate of LVEDP without having to
advance and wedge the catheter.
Pulmonary artery catheters can also be used to measure
mixed venous saturations and CO via the Fick principle by
analysis of blood aspirated from the catheter’s distal port.
Typically, most CO measurements are made by electronic
analysis of a thermal wash-out curve of ﬂuid of a known
temperature detected proximally at the point of injection
and distally at a thermistor located 4 cm from the catheter
tip. Continuous measurement of CO is accomplished with
catheters containing an additional thermal ﬁlament and a
computation module. The latter system requires occasional
set-up time and calibration. Data from either of these
catheters can be used to derive right ventricular ejection
fraction (REF) and right ventricular end-diastolic volume
(RVEDV). Thus, in addition to titration of ﬂuids, the impact
of inotropes, vasoconstrictors, and other interventions can
be measured and followed. Low REF has been found to be
helpful in identifying myocardial depression and as a marker
of poor prognosis in septic patients [12]. In cardiac surgery
patients, REF and RVEDV may be helpful in early detection
of impaired right ventricular function secondary to right
coronary artery stenosis [13].
As with the CVP, PAWP measurements are dependent
on myocardial compliance. Multiple studies on ICU patients
have shown that PAWP in acute illness correlates poorly
or inconsistently with left ventricular end-diastolic volume
(LVEDV) [14–17]. Comparisons of PAWP and right RVEDV
index found the latter to correlate more reliably with
changes in cardiac index (CI) [18, 19]. Though RVEDV
by PAC has been found to be consistent with diﬀerent
methods of measurement, such as ventriculography [20]a n d
angiography [21, 22], other investigators have found the data
less convincing [23, 24]. De Simone et al. compared 3D
echocardiography data with PAC-derived RVEDV and found
no signiﬁcant correlation between the two [25].
For most of the past three decades, use of the PAC
was based on the uncontested assumption that targeted
improvement of physiologic parameters to supranormal
endpoints is a desirable strategy. This approach began in
the early 1970s when Shoemaker and colleagues described
a pattern of higher ventricular performance, oxygen deliv-
ery, and oxygen consumption which predicted survival in
trauma patients [26]. Subsequent studies in surgical patients
seemed to conﬁrm the survival beneﬁt of using the PAC
to facilitate increasings CO and oxygen delivery [27, 28].
In high-risk surgical patients, a signiﬁcant reduction in
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a protocol attempting to reach supranormal cardiac indices
(CI ≥ 4.5L/min/m2), [29]). A similar reduction in mortality
(5.7% versus 22%) was seen in high-risk surgical patients
randomized to a protocol where an oxygen delivery index of
greater than 600 mL/min/m2 was achieved by dopexamine
infusion [30], and a later study of trauma patients demon-
strated a decrease in mortality from 37% to 18% with a
similar protocol of PAC-facilitated endpoints [31].
Using the PAC to facilitate increased oxygen delivery in
medical and surgical ICU patients was the next natural step.
However, therapy designed to achieve such supranormal
values had no eﬀect in one study where therapy was targeted
t oa c h i e v eas u p r a n o r m a lC Ia n dn o r m a lS v O 2 [32], did
not improve outcome in patients randomized to receive an
O2 delivery index of ≥600mL/min/m2 in another [33], did
not improve outcomes in septic patients where supranormal
indices of DO2 and VO2 were attempted [34], and, ﬁnally,
decreased survival in a study using the PAC to guide supra-
normal hemodynamics [35]. In the studies above, use of the
PAC was intertwined with a speciﬁc protocol for achieving
key therapeutic endpoints, thus seeming to negate the value
of the technology, when the ﬂaw may have been the endpoint
thetechnologywasusedtoachieve.Amorerecentgeneration
of controlled studies comparing pulmonary artery and CVP
catheters with less stringent, and in some cases clinician-
generated endpoints, have again shown no beneﬁt of the
catheter per se in high-risk surgical patients [36], patients
with shock and sepsis [37], and adult patients with the acute
respiratory distress syndrome (ARDS) [38]. In the Canadian
study of surgical patients, the PAC was associated with a
higher incidence of nonfatal pulmonary embolism[36].
Use of PACs has fallen over the last ten years due to the
factors cited above, as well as due to higher complication
rates [39], frequent misinterpretation of PAC data [40], and
relative success with CVP-based methods for resuscitation in
septic shock [11]. The American Society of Anesthesiologist
Practice Guidelines recommend PAC for high-risk surgical
patients only [41].
At present no study has demonstrated a positive associ-
ation between PAC use for ﬂuid management and survival
[42]. Many of the randomized studies allowed physician
exclusion of patients thought to beneﬁt from the monitoring
system, such as patients with heart failure and pulmonary
hypertension where ﬂuid management is only one of a
handful of variables under active scrutiny and manipulation.
Such use is likely to be highly individualized and unlikely
to conform to a set protocol or study design that will allow
a deﬁnitive statement of beneﬁt. It is therefore prudent to
be aware of the capabilities of the PAC and maintain an
openmindaboutitspotentialvaluewhenafullerphysiologic
picture may be necessary to make decisions regarding ﬂuid
responsiveness and volume status.
4. CardiorespiratoryInteractionsand
DynamicAnalysisofFluidStatus
Cardiac output and blood pressure interact with the res-
piratory system in a predictable manner according to the
Table 1: Cardiorespiratory interactions used to predict volume
responsiveness are listed. RV: right ventricle; LV: left ventricle.
Mode of
inspiration
RV preload RV postload LV preload LV postload
Spontaneous ⇑⇓⇓⇑
Controlled ⇓⇑⇑⇓
relationships indicated in Table 1. With positive pressure
ventilation, venous return to the left ventricle is augmented,
causing a rise in cardiac output and blood pressure during
early inspiration. Later, the decrease in RV preload caused by
positive intrathoracic pressure causes a drop in LV preload
and systemic blood pressure [42]. Compared to the static
hemodynamic parameters (CVP, PAWP), which are mea-
sured at one point in the cardiac cycle, dynamic parameters
have been shown to be more accurate in assessment of
intravascular volume and ﬂuid responsiveness.
It is well recognized that pulsus paradoxus, or an
inspiratory fall in systolic blood pressure by more than
10mmHg, is seen in critically ill patients with hypovolemia.
With hypovolemia, the myocardium is at the steep portion
of the Frank-Starling curve, so any minor variation in the
preload with inspiration or expiration can cause appreciable
changes in CO and blood pressure. Some rather direct
and accurate inferences regarding intravascular volume can
be made from analysis of arterial pressure waveforms and
Doppler analysis of aortic blood ﬂow. Ironically, while
positivepressureventilationisused,theaccuracyofpressure-
based measures of ﬂuid responsiveness such as CVP is
highlydebated,whileﬂow-basedmeasurementsachievetheir
highest accuracy. Indices of intravascular ﬂuid and preload
assessmentderivedfrompositivepressureventilator-induced
arterial blood pressure changes include systolic pressure
variability, the respiratory systolic variation test, stroke
volume variability, and respiratory changes in arterial pulse
pressure.
4.1. Systolic Pressure Variability (SPV). The range of blood
pressure (diﬀerence between maximal and minimal systolic
BP) during a single positive pressure breath is deﬁned as
SPV. The baseline systolic pressure is taken using a short
apneic period. SPV has 2 components, delta up and delta
down, corresponding to the diﬀerence between the baseline
and the peak amplitude during early expiration and at end
inspiration, respectively. SPV refers to the sum of delta up
and delta down or the total amplitude variation (Figure 2).
Beside intravascular volume status, SPV and its two
components can be aﬀected by a multitude of factors
which include arrhythmias, chest wall and lung compliance,
abdominal pressure, method of ventilation (spontaneous or
mechanical), and myocardial function [43–46]. All these fac-
tors remaining stable, variations in SPV will reﬂect changes
in intravascular volume. With a normal myocardium func-
tioning at the steep portion of the Frank Starling Curve, SPV
is mainly due to delta down component, with a decrease
in ventricular ﬁlling with positive pressure ventilation [44].Anesthesiology Research and Practice 5
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Figure 2: Arterial line tracings showing systolic pressure variation
during the respiratory cycle. The pressure at end expiration deﬁnes
baseline systolic pressure. SPV has two components, delta up and
delta down, corresponding to systolic pressure waves reading at
peak amplitude of early inspiration (the upward component or
deltaup)andatendinspiration(thedownwardcomponentordelta
down). The total amplitude variation or the sum of delta up and
delta down is thus the SPV, shown with the arrow on the right of
the diagram.
On the other hand, SPV is comprised of a delta up com-
ponent in a patient with a failing myocardium, which is
preloadinsensitivebutresponsivetoafterloadreductionwith
positive pressure ventilation [47]. The increase in pressure
surrounding the heart decreases transmural pressure dur-
ing systole (and hence afterload), thereby improving the
ejection fraction. No exact values of SPV for determina-
tion of hypovolemia have been established. In a study by
Rooke, SPV less than 5mmHg and delta down compo-
nent less than 2mmHg showed absence of hypovolemia
[48].
Other methods of analyzing ﬂuid responsiveness from
respiration-induced changes in arterial pulse waves have
been described and validated. The respiratory systolic vari-
ation test uses the slope obtained by the minimal systolic
BP during a ventilator maneuver involving four successive
incremental positive pressure breaths [49]. Greater negative
slope was found to correlate with increasing amounts of
hemorrhage [50]. R e s p i r a t o ryc h a n g ei na rt e ri a lp u l s ep r e s s u r e
(DPp) is deﬁned as the diﬀerence in pulse pressure of the
highest (Ppmax) and lowest magnitude (Ppmin) over several
respiratory cycles, divided by the mean of the 2 values,
expressed as a percentage. In one study, a DPp of 13%
diﬀerentiated ﬂuid responders from nonresponders [51].
Stroke volume variability is an index that is based on beat-
to-beat variability in the arterial pulse during the respiratory
cycle [52].
While all of these parameters can be measured manually
via printouts from raw arterial pressure waves, a number
of commercial systems discussed below provide automated
analysis and trending along with means of measuring cardiac
output. The PiCCO system (PULSION Medical Systems AG,
Munich,Germany)derivesvolumetricparametersfromarte-
rial waveforms via a set of algorithms termed pulse contour
analysis. The latter method, ﬁrst described by Wesseling
et al., computes the end-diastolic to end-systolic change
in pressure over systemic vascular resistance (SVR) [53].
The beat-to-beat change in the shape of the arterial pressure
waveform reﬂects the changes in the impedance of the aorta.
Absolute values of aortic impedance and SVR obtained
by thermodilution (using the same monitor) are necessary
for calibration of the monitor; from this, values of stroke
volume, cardiac output, and vascular resistance are derived.
Thus, pulse contour is able to convert pressure-based signals
such as pulse pressure and pulse pressure variability into
analogous volume-based signals. Validation studies with the
PAC showed that pulse contour analysis was able to track
increases in stroke volume accurately in volume responsive
postcardiac surgery patients [54, 55]. Likewise, through use
of SVV as a gauge of volume responsiveness, investigators
were able to predict intraoperative ﬂuid requirements for
obese patients undergoing bariatric surgery [56].
In principle, the monitor could indicate ﬂuid respon-
siveness via pulse variability with mechanical ventilation as
a stand-alone monitor, but, with calibration, an additional
wealth of information is available. Unlike the PAC, the injec-
tate signal is collected at one of the large arteries outside of
the thorax (femoral, axillary, or brachial) and thus measures
transpulmonary blood ﬂow. Mathematical analysis of the
transpulmonary dilution curve can be carried out further
to derive actual ﬂuid compartments within the thorax.
Two of the derived parameters, extravascular lung water
(EVLW) and global end-diastolic volume (GEDV), are of
particular interest. Both GEDV and the related intrathoracic
blood volume (ITBV) are volumetric preload parameters
in contrast to the more commonly used pressure-derived
parameters from CVP and PACs. Changes in GEDV have
correlated better with changes in stroke volume than with
changes in CVP [57]. The ability to measure extravascular
lung water carries the hope of being able to diﬀerentiate
and follow problems such as pulmonary edema and ARDS
[58], the latter with a positive survival associated with which
excess ﬂuid use could be avoided [38, 59]. An observational
study of septic patients by Martin demonstrated a better
survival in those with lower EVLW [60]. Further, ﬂuid
therapy algorithms guided by GEDV and EVLW rather than
clinicalassessmentcanleadtofasterresolutionofpulmonary
edema, shortened requirement for vasopressors, mechanical
ventilation, and thereby ICU stays [61, 62].
Aninvestigationofpostoperativecardiacsurgerypatients
showed that CO derived by PAC and transpulmonary
method is clinically comparable [63]. The advantage of
transpulmonary thermodilution over the PAC is that it does
not require insertion into a pulmonary artery (reduce risk of
arrhythmias and pulmonary artery rupture), though it does
require a CVC and an arterial catheter and their attendant
complications. Artifactual increases in CO introduced by
tricuspid regurgitation in PAC use would not be present with
use of transpulmonary blood ﬂow measurement. Inability to
measure mixed venous oxygen saturations can be partially
compensated by trending central venous saturations via a
CVC.
Similar measurements using transpulmonary lithium
dilution and detection by an ion selective electrode are the
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CO and pulse wave analysis, the PulseCO (LiDCO Ltd,
London,UK)[64].Theconcentration-timecurveforlithium
ion calibration is read out on an attachment appended to the
tubing on an existing artery after injecting from any intra-
venous line. The analytic algorithm is diﬀerent from pulse
contour in a few fundamental ways. The resulting “pulse
power” computation is not sensitive to changes in pulse
pressureamplitudefoundindistalarteriesandisnotaﬀected
byunder-orover-dampeningofarterialpressuretransducers
[65]. With these corrections built into the computational
scheme, the LiDCO does not require a central arterial line.
T h el e s si n v a s i v en a t u r eo ft h i ss y s t e mm a ya l s op r e s e n t
advantages in certain patient populations such as those with
limited central access or severe arterial disease. Despite these
advantages, the LIDCO system does not give data such as
GEDV and ITBV, and calibration measurements are limited
by a desire to minimize lithium exposures (the number is,
however, not deﬁned by the manufacturer). The accuracy of
thesystemisalsolowonpatientsontherapeuticlithium[65].
A more recent iteration of the LiDCO, the “LiDCO rapid,”
uses a software-based nomogram to estimate stroke volume
without the need for lithium calibration. Accuracy of the
latter has been shown to diﬀer from thermodilution-based
cardiac output measurements in cardiac surgery patient; the
thought being that the recalibration may be required in such
dynamic situations where the arterial compliance ﬂuctuates
widely through the course of a case (i.e., pre- versus post-
cardiopulmonary bypass) [66]. Pulse wave analysis systems
including both LiDCO and PiCCO have been used in
combination with passive leg raising to accurately predict
ﬂuid responsiveness [67].
Another recently introduced system called FloTrac/
Vigileo (Edward Lifesciences, Irvine, Calif) has also been
designed to function without external calibration. Instead
individual demographic data (height, weight, age, and sex)
are used with arterial waveform analysis to calculate CO,
the principle being that SV is proportional to pulse pressure
(PP). In addition, the FloTrac can also calculate SVV, and
if a central venous catheter is present, SVR and central
venous saturation can be obtained. Like the LiDCO rapid,
the FloTrac features ease of use and requires only an arterial
catheter [68]. A study comparing PiCCO with FloTrac found
FloTrac/Vigileo (2nd generation software) to be as accurate
as the PiCCO in predicting ﬂuid responsiveness using SVV,
although the threshold value of SVV for the FloTrac/Vigileo
was lower (9.6%) than for the PiCCO (12.1%) [69]. A
meta-analysis found FloTrac in acceptable agreement with
CO derived with thermodilution techniques. However, the
authors concluded that, in patients with rapid hemodynamic
changes, hyperdynamic circulation, aortic regurgitation and
intraaortic balloon pump counterpulsation, its use was
questionable [68].
Pressure Recording Analytical Method (PRAM) (Most-
Care device, Vytech, Padu, Italy) is another device that
estimates CO from the area under the arterial pressure
wave. No external calibration is required as with FloTrac.
A study in hemodynamically stable children comparing
Doppler echocardiography found PRAM reliable, though
more validation studies are required [70].
5.Echocardiography
From its initial use in outpatient settings in 1970s, echocar-
diography has found its place in all inpatient settings,
ranging from the operating rooms to the intensive care unit
(ICU). Diﬀerent modalities of ultrasound include transtho-
racic echo being most noninvasive and portable, while the
more invasive nature of esophageal Doppler and trans-
esophageal echo is well tolerated in anesthetized patients.
Nevertheless, all echographic techniques spare the patient
the complications related to vascular access and indwelling
devices. Also, in contrast to the PAC which is dependent
on pressure measurements to make volume determinations,
echocardiography relies on direct visualization of the car-
diac anatomy and ﬂow dynamics. Moreover, in patients
wherecausesofcirculatoryfailureoverlap,echocardiography
provides the ability to evaluate structural abnormalities
(pericardial tamponade), contractility (ejection fraction),
besides assessment of intravascular volume.
5.1. Transthoracic Echo (TTE). Improved image quality with
portable study echo machines in the last decade has made
TTE a popular tool for intravascular ﬂuid assessment in
the ICU. More recently, its use has been advocated in the
perioperative settings due to its ability to provide quick,
noninvasive functional and ﬂuid assessment. Right heart
preload can be reliably obtained by direct measurement of
the inferior vena cava diameter (IVC) variations with respi-
ration (Figure 3) and also by right and left ventricular end-
diastolic volumes. One study showed that a 50% decrease
in IVC diameter (caval index), seen by subcostal views with
spontaneous breathing, correlated with an RA pressure of
less than 10mmHg (mean SD 6 ± 5), as measured by CVP
measurements [71]. Recent study in emergency department
settings found caval index measurement a useful noninvasive
tool for initial determination of CVP [72].
In mechanically ventilated patients, IVC variations with
respiration (Delta DIVC) of 12% diﬀerentiated patients
who responded with increased CO to a ﬂuid bolus from
nonresponders [73]. In another study with mechanically
ventilated septic patients, the CVP and the IVC diameter
increase on inspiration (distensibility index (dIVC)) was
measured before and after a gelatin ﬂuid challenge of 7
mL/kg. Response was measured as an increase in CI of
15% or more. dIVC greater than 18% predicted ﬂuid
responsiveness with a sensitivity and speciﬁcity of Ninety
percent. CVP, on the other hand, correlated poorly with CI
(r = 0.17, P = .4 5 )a n dd I V C[ 74]. In spite of diﬃculty
in visualizing IVC in postabdominal surgeries and obese
patients, TTE provides a quick, noninvasive and reliable
method of volume status of the patient.
5.2. Transesophageal Echocardiography (TEE). Besides car-
diac anesthesia, TEE is now used routinely in other complex
and long surgeries (e.g., liver transplant), especially among
patients with known cardiac pathology. In our operating
rooms, the quick availability of TEE machines makes thisAnesthesiology Research and Practice 7
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Figure 3: A subcostal view of the cavoatrial junction and adjacent
structures. RA: right atrium; IVC: inferior vena cava; LIV: liver.
a ﬁrst-line diagnostic modality for experienced users when
unexpected hemodynamic instability is encountered.
For general use, the main focus is on intravascular
volume status assessment and overall cardiac function. In
the ICU, TEE is recommended when diagnostic information
cannot be adequately obtained by TTE [75]. Limitations of
TEE include the lack of availability of trained personal and
equipment, the requirement of adequate sedation or intu-
bation, and the impracticality for continuous postoperative
use. Also, TEE is an invasive procedure and contraindicated
in patients with esophageal strictures and malformation.
As with TTE for IVC measurements to determine
preload, TEE can be used to measure SVC collapsibility.
Volume expansion was found to decrease SVC collapse,
decrease RV stroke volume variation, and increase CI in
a study in 22 mechanically ventilated ARDS patients with
septic shock [76]. A collapsibility index of 36% was found
to predict an 11% increase in CI following a ﬂuid bolus in a
separate study [77].
Both TTE and TEE allow visual estimation of ventricular
volume. Ninety percent of the stroke volume is obtained by
ventricularshorteningintheshortaxis[78].Therefore,mea-
surement of the LV end-diastolic area using mid-transgastric
short axis view by TEE can give a reliable estimate of
LV end diastolic volume [79]. In practice, a qualitative
assessment of LVEDA provides a quicker and quite reliable
assessment, as Leung and Levine report that systolic cavity
obliteration is 100% sensitive in detecting hypovolemia [80].
Fluid challenge in these cases can be followed by serial echo
views of ventricular ﬁlling and correlation with the CVP.
On the other hand, distended left ventricle with decreased
EF would indicate minimal beneﬁt from a ﬂuid challenge.
Additionally, a distended right ventricle and empty left
ventricle may indicate right ventricular failure possibly from
acute pulmonary embolism or pulmonary vascular disease.
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Figure 4: Esophageal Doppler tracings from descending aorta
blood ﬂow. Flow time and peak velocity are indicated by dashed
and vertical arrows, respectively. Parameters derived from the latter
measurements include corrected ﬂow time (FTc), acceleration, and
stroke distance. The area under the curve (AUC) is equivalent to
strokedistance,thelengthtraveledbyanerythrocyteduringasingle
cardiac cycle. Assuming that the ﬂow is via a cylindrical path, the
stroke volume (SV) is the product of aortic cross-sectional area
and the stroke distance. Aortic blood ﬂow is calculated from the
product of heart rate and calculated SV and is not exactly equal to
true cardiac output, as approximately 10% of total cardiac output is
diverted to subclavian and cerebral arteries upstream to where ﬂow
is measured.
5.3. Esophageal Doppler Monitoring (EDM). Using the
Doppler principle to calculate blood ﬂow velocity in the
aorta, EDM can be used to provide minimally invasive
continuous COmonitoring. EDMcomprisesofasmall,thin,
ﬂexible probe with a Doppler transducer at the tip, inserted
35 cm into the esophagus, and has a tolerability similar
to a nasogastric tube [81]. A continuous Doppler beam is
used to generate ﬂow velocity proﬁle by analyzing reﬂected
ultrasound waves from the moving red blood cells. Figure 4
shows a ﬂow-time tracing generated by EDM. Flow time is
deﬁned as the time needed by the left ventricle to eject the
SV and is represented on the waveform from the start of
the upstroke to its return to baseline. As ﬂow time is also
dependant on the heart rate, “corrected ﬂow time” or FTc
analogous to QTc in the electrocardiogram (ECG) is used in
ﬂowcalculations.Areaundertheﬂowtimecurveiscalledthe
strokedistance.Combiningwithcross-sectionalareacangive
thestrokevolume.Thecross-sectionalareaofthedescending
aorta can be obtained using nomograms (based on patients’
height and weight) or measured directly with the M-mode
by the EDM. Correction factor of 1.4 is used to adjust for
blood lost to the coronaries and upper body circulation [81].
Additional analysis of ﬂow velocity proﬁle (peak velocity and
upslope) can be used to evaluate left ventricular sensitivity to
afterload and contractility.
While nearly emerging devices for ﬂuid management
have sought to ﬁrst establish themselves as similar to the
“gold standard” PAC, the initial studies of EDM are relatively
unique in their attempt to associate a positive clinical out-
come with device use. In postsurgical patients, hypovolemia
is a notorious cause of splanchnic hypoperfusion, prolonged
hospital stays, and even increased mortality in moderate- to
high-risk surgical patients [82–84]. With the use of a ﬂuid
managementprotocolbuiltaroundusingthecontinuousCO
and FTc parameters of EDM monitoring, investigators were8 Anesthesiology Research and Practice
able to reduce the time to bowel motility, decrease the time
to solid food intake, and shorten hospital stay [82, 85].
An analogous method for evaluation of cardiac output
is based on estimation of blood ﬂow via analysis of electrical
bioimpedance. With electrical velocimetry (EV), all measure-
ments are made via four ECG electrodes applied along one
side of the patient’s body. A small amplitude alternating
current is applied to one pair of electrodes, while the other
detects the change in electrical signal through the cardiac
cycle. When blood moves forward through the ascending
aorta during ventricular ejection, red cells tend to align
more along the body’s long axis, and create less impedance
of electrical signals traveling along the same vector. Thus,
from analysis of the electrical signal during the cardiac cycle,
velocity and ﬂow time parameters are generated and used to
calculate stroke volume and cardiac output.
Comparisons between EV and thermodilution cardiac
output measurements show a good level of agreement over
a wide range of outputs in adult cardiac surgery patients and
critically ill adults [86, 87]. An excellent correlation (r =
0.97) was found between EV and cardiac output measure-
ments made by the Fick method (using direct measurements
of VO2) in children with congenital heart disease, and EV
measurements correlated well with Doppler measurements
made via transesophageal echo in cardiac surgery patients
[88, 89].
Limitations to EDM use are similar to TEE. In addition,
severe aortic regurgitation, severe lung disease, altered tho-
racic blood ﬂow, and presence of intra-ortic balloon pump
can alter accuracy of EDM [81].
6. Conclusion
Resuscitation of the hypotensive patient in the perioperative
settingcanbechallenging.Accurateandtimelyassessmentof
ﬂuid status and ﬂuid responsiveness are cornerstones in the
management of the hypotensive patient. Both hypovolemia
and hypervolemia can be harmful. Goal-directed ﬂuid
management can result in the appropriate use of ﬂuids,
vasopressors, and inotropes, resulting in improved patient
outcomes. Invasive, noninvasive, static, and dynamic mon-
itoring methods have strengths and limitations. Continual
monitoring of unstable patients through the resuscitation
periodutilizingacombinationoftechniquescanimprovethe
utility of hemodynamic information, improve the accuracy
of assessments of volume status, and improve patient
outcomes.
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